Evidence map›Paper›PMID 31239528›Full record

ArticleScientific reports2019

Purkinje cell number-correlated cerebrocerebellar circuit anomaly in the valproate model of autism.

Tamás Spisák, Viktor Román, Edit Papp, Rita Kedves, Katalin Sághy, Cecília Katalin Csölle, Anita Varga, Dávid Gajári, Gabriella Nyitrai, Zsófia Spisák and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Tamás SpisákPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Viktor RománPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.ORCID http://orcid.org/0000-0002-4849-3591
Edit PappInstitute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
Rita KedvesPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Katalin SághyPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Cecília Katalin CsöllePharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Anita VargaPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Dávid GajáriPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Gabriella NyitraiPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Zsófia SpisákPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Zsigmond Tamás KincsesPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
György LévayPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Balázs LendvaiPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
András CzurkóPharmacology and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary. czurkoa@richter.hu.ORCID http://orcid.org/0000-0002-1985-7296
Gedeon Richter (Hungary) · HUHUN-REN Institute of Experimental Medicine · HUUniversity of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While cerebellar alterations may play a crucial role in the development of core autism spectrum disorder (ASD) symptoms, their pathophysiology on the function of cerebrocerebellar circuit loops is largely unknown. We combined multimodal MRI (9.4 T) brain assessment of the prenatal rat valproate (VPA) model and correlated immunohistological analysis of the cerebellar Purkinje cell number to address this question. We hypothesized that a suitable functional MRI (fMRI) paradigm might show some altered activity related to disrupted cerebrocerebellar information processing. Two doses of maternal VPA (400 and 600 mg/kg, s.c.) were used. The higher VPA dose induced 3% smaller whole brain volume, the lower dose induced 2% smaller whole brain volume and additionally a focal gray matter density decrease in the cerebellum and brainstem. Increased cortical BOLD responses to whisker stimulation were detected in both VPA groups, but it was more pronounced and extended to cerebellar regions in the 400 mg/kg VPA group. Immunohistological analysis revealed a decreased number of Purkinje cells in both VPA groups. In a detailed analysis, we revealed that the Purkinje cell number interacts with the cerebral BOLD response distinctively in the two VPA groups that highlights atypical function of the cerebrocerebellar circuit loops with potential translational value as an ASD biomarker.

Indexed as

AnimalsAutistic DisorderCalbindinsCell CountDisease Models, AnimalFemaleMagnetic Resonance ImagingPurkinje CellsRatsRats, Sprague-DawleyValproic AcidCalbindinsValproic Acid

Identifiers

PMID31239528
PMCPMC6592903
OpenAlexW2955413852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.